Physician
Cardiology
Dr. Abdul R. Qureshi, MD
|
|
Give Review
Abdul R. Qureshi is an expert in the field of Cardiology. He graduated from King Edward Medical University. He received awards:"CMS Meaningful Use Stage 1 Certification". Abdul R. Qureshi is a published doctor. He published 101 publications, including: 'Factors predicting malnutrition in hemodialysis patients: a cross-sectional study.' Dr. Abdul R. Qureshi accepts Medicare payments and is listed with Medicare.gov.
Publications
- Influence of Body Mass Index on the Association of Weight Changes with Mortality in Hemodialysis Patients.
- Can renal nutrition education improve adherence to a low-protein diet in patients with stages 3 to 5 chronic kidney disease?
- Baseline levels and trimestral variation of triiodothyronine and thyroxine and their association with mortality in maintenance hemodialysis patients.
- Prolactin Levels, Endothelial Dysfunction, and the Risk of Cardiovascular Events and Mortality in Patients with CKD.
- Metabolism of alprazolam (a marker of CYP3A4) in hemodialysis patients with persistent inflammation.
- Endogenous testosterone, endothelial dysfunction, and cardiovascular events in men with nondialysis chronic kidney disease.
- Testosterone deficiency is a cause of anaemia and reduced responsiveness to erythropoiesis-stimulating agents in men with chronic kidney disease.
- Circulating follistatin in patients with chronic kidney disease: implications for muscle strength, bone mineral density, inflammation, and survival.
- Protein-energy wasting modifies the association of ghrelin with inflammation, leptin, and mortality in hemodialysis patients.
- Factors associated with the quality of life of incident patients on PD in Brazil (BRAZPD).
- Left Ventricular Hypertrophy in Incident Dialysis Patients Randomized to Treatment with Hemofiltration or Hemodialysis: Results from the ProFil Study.
- Uraemic sera stimulate lipolysis in human adipocytes: role of perilipin.
- High-mobility group box-1 protein (HMGB1) is increased in antineutrophilic cytoplasmatic antibody (ANCA)-associated vasculitis with renal manifestations.
- Effect of circulating soluble receptor for advanced glycation end products (sRAGE) and the proinflammatory RAGE ligand (EN-RAGE, S100A12) on mortality in hemodialysis ...
- Vitamin D deficiency in dialysis patients: effect of dialysis modality and implications on outcome.
- Soluble CD14 levels, interleukin 6, and mortality among prevalent hemodialysis patients.
- CCR5 deletion protects against inflammation-associated mortality in dialysis patients.
- Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.
- Elevated serum macrophage migration inhibitory factor (MIF) concentrations in chronic kidney disease (CKD) are associated with markers of oxidative stress and endothel...
- Low serum testosterone increases mortality risk among male dialysis patients.
- Additive effects of soluble TWEAK and inflammation on mortality in hemodialysis patients.
- Novel links between the long pentraxin 3, endothelial dysfunction, and albuminuria in early and advanced chronic kidney disease.
- Consequences of low plasma histidine in chronic kidney disease patients: associations with inflammation, oxidative stress, and mortality.
- High Mobility Group Box Protein-1 correlates with renal function in chronic kidney disease (CKD).
- ADMA levels correlate with proteinuria, secondary amyloidosis, and endothelial dysfunction.
- Homocysteine-lowering is not a primary target for cardiovascular disease prevention in chronic kidney disease patients.
- Anti endothelial cell autoantibodies selectively activate SAPK/JNK signalling in Wegener's granulomatosis.
- Obese sarcopenia in patients with end-stage renal disease is associated with inflammation and increased mortality.
- Associations between the CYBA 242C/T and the MPO -463G/A Polymorphisms, Oxidative Stress and Cardiovascular Disease in Chronic Kidney Disease Patients.
- Comparison of nutritional and inflammatory markers in dialysis patients with reduced appetite.
- Cholinergic anti-inflammatory pathway activity and High Mobility Group Box-1 (HMGB1) serum levels in patients with rheumatoid arthritis.
- Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD.
- Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD.
- Statin treatment and diabetes affect myeloperoxidase activity in maintenance hemodialysis patients.
- Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
- Accelerated lean body mass loss in incident chronic dialysis patients with diabetes mellitus.
- Circulating inflammatory endothelial cells contribute to endothelial progenitor cell dysfunction in patients with vasculitis and kidney involvement.
- Body fat mass and serum leptin levels influence epoetin sensitivity in patients with ESRD.
- Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin.
- Heat sterilization of peritoneal dialysis solutions influences ingestive behavior in non-uremic rats.
- Community acquired and post-transfusion hepatitis C "is there a difference?".
- Determination of free amino acids in biological samples: problems of quantitation.
- Plasma osteoprotegerin, arterial stiffness, and mortality in normoalbuminemic Japanese hemodialysis patients.
- Clinical and biochemical implications of low thyroid hormone levels (total and free forms) in euthyroid patients with chronic kidney disease.
- Gamma glutamyltranspeptidase activity and viral hepatitis in dialysis population.
- Acute effects of peritoneal dialysis solutions on appetite in non-uremic rats.
- Inflammation contributes to low plasma amino acid concentrations in patients with chronic kidney disease.
- Human liver sinusoidal endothelial cells induce apoptosis in activated T cells: a role in tolerance induction.
- Changes in fat mass after initiation of maintenance dialysis is influenced by the uncoupling protein 2 exon 8 insertion/deletion polymorphism.
- Impact of inflammation on epigenetic DNA methylation - a novel risk factor for cardiovascular disease?
- Telomere attrition is associated with inflammation, low fetuin-A levels and high mortality in prevalent haemodialysis patients.
- Plasma pentraxin 3 in patients with chronic kidney disease: associations with renal function, protein-energy wasting, cardiovascular disease, and mortality.
- Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance.
- Whole blood cytokine attenuation by cholinergic agonists ex vivo and relationship to vagus nerve activity in rheumatoid arthritis.
- The long pentraxin PTX-3 in prevalent hemodialysis patients: associations with comorbidities and mortality.
- Temporal discrepancies in the association between the apoB/apoA-I ratio and mortality in incident dialysis patients.
- Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patients.
- Are insulin-like growth factor and its binding proteins 1 and 3 clinically useful as markers of malnutrition, sarcopenia and inflammation in end-stage renal disease?
- Quantitation of free amino acids in plasma and muscle samples in healthy subjects and uremic patients by high-performance liquid chromatography and fluorescence detect...
- Icodextrin metabolism and alpha-amylase activity in nonuremic rats undergoing chronic peritoneal dialysis.
- Soluble adhesion molecules in end-stage renal disease: a predictor of outcome.
- Physiological saline is not a biocompatible peritoneal dialysis solution.
- The prognostic impact of fluctuating levels of C-reactive protein in Brazilian haemodialysis patients: a prospective study.
- Dioctyl sodium sulphosuccinate increases net ultrafiltration in peritoneal dialysis.
- Nutritional status, muscle composition and plasma and muscle free amino acids in renal transplant patients.
- J-shaped mortality relationship for uric acid in CKD.
- Low serum fetuin-A concentration predicts poor outcome only in the presence of inflammation in prevalent haemodialysis patients.
- The Brazilian Peritoneal Dialysis Multicenter Study (BRAZPD) : characterization of the cohort.
- Plasma pentosidine and total homocysteine levels in relation to change in common carotid intima-media area in the first year of dialysis therapy.
- Peroxisome proliferator-activated receptor gamma polymorphisms affect systemic inflammation and survival in end-stage renal disease patients starting renal replacement...
- Plasma pentosidine is associated with inflammation and malnutrition in end-stage renal disease patients starting on dialysis therapy.
- Factors predicting malnutrition in hemodialysis patients: a cross-sectional study.
- Daily exposure to dialysis fluid results in changes in peritoneal transport.
- Vitamin D receptor gene, biochemical bone markers and bone mineral density in Mexican women on dialysis.
- Tryptophan and its metabolites in patients on continuous ambulatory peritoneal dialysis and following renal transplantation.
- Influence of nutritional status on plasma and erythrocyte sulphur amino acids, sulph-hydryls, and inorganic sulphate in end-stage renal disease.
- Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients.
- Hand-grip muscle strength, lean body mass, and plasma proteins as markers of nutritional status in patients with chronic renal failure close to start of dialysis therapy.
- Hyperhomocysteinemia in relation to plasma free amino acids, biomarkers of inflammation and mortality in patients with chronic kidney disease starting dialysis therapy.
- Malnutrition and inflammation are associated with impaired pulmonary function in patients with chronic kidney disease.
- Improvement of cardiac function after haemodialysis. Quantitative evaluation by colour tissue velocity imaging.
- Association between residual renal function, inflammation and patient survival in new peritoneal dialysis patients.
- The influence of hepatitis C and iron replacement therapy on plasma pentosidine levels in haemodialysis patients.
- The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammation.
- Endothelial dysfunction in type-2 diabetics with early diabetic nephropathy is associated with low circulating adiponectin.
- Serum visfatin concentration and endothelial dysfunction in chronic kidney disease.
- Automated peritoneal dialysis as the modality of choice: a single-center, 3-year experience with 458 children in Mexico.
- Is fetuin-A/alpha2-Heremans-Schmid glycoprotein associated with the metabolic syndrome in patients with chronic kidney disease?
- Muscle atrophy, inflammation and clinical outcome in incident and prevalent dialysis patients.
- Bone mineral density in end-stage renal disease patients: association with wasting, cardiovascular disease and mortality.
- Elevated serum levels of S-adenosylhomocysteine, but not homocysteine, are associated with cardiovascular disease in stage 5 chronic kidney disease patients.
- Associations of VEGF and its receptors sVEGFR-1 and -2 with cardiovascular disease and survival in prevalent haemodialysis patients.
- Low levels of IgM antibodies against phosphorylcholine-A increase mortality risk in patients undergoing haemodialysis.
- Variations in graft and patient survival after kidney transplantation in Sweden: caveats in interpretation of center effects when benchmarking.
- Hyperinsulinemia and insulin resistance, early cardiovascular risk factors in children with chronic kidney disease.
- N-terminal pro-brain natriuretic peptide independently predicts protein energy wasting and is associated with all-cause mortality in prevalent HD patients.
- Bicarbonate-based peritoneal dialysis solution has less effect on ingestive behavior than lactate-based peritoneal dialysis solution.
- Abdominal fat deposition is associated with increased inflammation, protein-energy wasting and worse outcome in patients undergoing haemodialysis.
- Predictors of carotid artery intima-media thickness in chronic kidney disease and kidney transplant patients without overt cardiovascular disease.
- Inflammation modifies the association of osteoprotegerin with mortality in chronic kidney disease.
Schools
King Edward Medical University
St Marys Health Center
University Oreg Health Science Center
Doctors Specialties
- Internal Medicine
- Cardiology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Oregon Health & Science University -
King Edward Medical University
Drug Facts
| NPI NUMBER | 1245216993 | |
| NPPES Provider LastName | QURESHI | |
| NPPES Provider FirstName | ABDUL | |
| NPPES Provider ZIPCode | 631282141 | |
| NPPES Provider State | MO | |
| Specialty Description | Cardiology | |
| Total Claim Count | 2174.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 12.0 | |
| Percent Opioid Claims | 0.55 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1245216993 |
| Last Name Of The Provider | QURESHI |
| First Name Of The Provider | ABDUL |
| View All |
Similar Doctors
|
|
Dr. Craig S. Siegel, MD |
|
Dr. Jeffrey P. Ciaramita, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Mark A. Friedman, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. William F. Southworth, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Luciano C. Amado, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Andrew J. Krainik, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Stephen J. Pieper, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael G. Goldmeier, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John M. Lasala, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ravi B. Mehra, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Douglas Mann, MD |
|
|
Dr. Susan R. Colbert Threats, MD |
|
Dr. Amita R. Bhalla, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hari Krishna Nallapaneni, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Enver N. Yalcin, MD |
|
|
Dr. Andrew A. Ziskind, MD |
|
|
Dr. Charles F. Carey, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael L. Shapiro, MD |